MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

Search

Omnicell Inc

Fechado

SetorSaúde

33.94 -0.56

Visão Geral

Variação de preço das ações

24h

Atual

Mín

33.17

Máximo

34.3

Indicadores-chave

By Trading Economics

Rendimento

-7.5M

-2M

Vendas

3.4M

314M

P/E

Médio do Setor

808.75

56.063

Margem de lucro

-0.645

Funcionários

3,580

EBITDA

-9.8M

21M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+70.42% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-767M

1.5B

Abertura anterior

34.5

Fecho anterior

33.94

Sentimento de Notícias

By Acuity

5%

95%

2 / 349 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

6 de abr. de 2026, 23:17 UTC

Ganhos

Samsung Forecasts Record First-Quarter Operating Profit

6 de abr. de 2026, 23:00 UTC

Ações em Alta

Stocks to Watch: Health Insurers, Mawson, Owlet

6 de abr. de 2026, 22:13 UTC

Grandes Movimentos do Mercado

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 de abr. de 2026, 21:46 UTC

Aquisições, Fusões, Aquisições de Empresas

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 de abr. de 2026, 17:09 UTC

Grandes Movimentos do Mercado

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 de abr. de 2026, 16:56 UTC

Notícias Principais

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 de abr. de 2026, 14:47 UTC

Grandes Movimentos do Mercado

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 de abr. de 2026, 00:00 UTC

Notícias Principais

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 de abr. de 2026, 23:58 UTC

Conversa de Mercado
Notícias Principais

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 de abr. de 2026, 23:50 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 de abr. de 2026, 23:36 UTC

Conversa de Mercado

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 de abr. de 2026, 23:15 UTC

Conversa de Mercado

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 de abr. de 2026, 22:52 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

6 de abr. de 2026, 22:52 UTC

Conversa de Mercado

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 de abr. de 2026, 22:14 UTC

Conversa de Mercado

Correction to Live Cattle Futures Article

6 de abr. de 2026, 20:56 UTC

Conversa de Mercado

Mexican Private Consumption Fell in January -- Market Talk

6 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Energy & Utilities Roundup: Market Talk

6 de abr. de 2026, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

6 de abr. de 2026, 19:58 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

6 de abr. de 2026, 19:58 UTC

Conversa de Mercado

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 de abr. de 2026, 19:11 UTC

Conversa de Mercado

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 de abr. de 2026, 19:06 UTC

Conversa de Mercado

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 de abr. de 2026, 19:03 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

6 de abr. de 2026, 19:03 UTC

Conversa de Mercado

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 de abr. de 2026, 18:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 de abr. de 2026, 17:59 UTC

Conversa de Mercado
Notícias Principais

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 de abr. de 2026, 17:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 de abr. de 2026, 16:33 UTC

Conversa de Mercado

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 de abr. de 2026, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

6 de abr. de 2026, 14:59 UTC

Ganhos

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

70.42% parte superior

Previsão para 12 meses

Média 58.2 USD  70.42%

Máximo 70 USD

Mínimo 49 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

7 ratings

6

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

2 / 349 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat